Genetic testing is on the cusp of a major revolution, which has the potential to shift not just how we understand our risk for disease, but how we practice healthcare. In the clinic today, genetic testing is used only in...

Lakes v. warehouses, analytics v. AI/ML, SQL v. everything else... As the technical capabilities of data lakes and data warehouses converge, are the separate tools and teams that run AI/ML and analytics converging as well?

AI/ML development is like reining in the natural world, more like physics and even metaphysics, where data and models are fluid. But this not just a philosophical observation; it has real implications for the margins, organizational structures, and building of such businesses. Especially as we’re in a tricky time of transition, where customers don’t even know what they’re asking for, yet are looking for AI/ML help or know it’s the future. So what does this all mean for the software value chain; for open source collaboration and commodification; for a new type of AI/ML company; and for the future of software businesses?

In this episode of the a16z Podcast, we talk about what the primary care of the future should actually look like and new ways we can understand what patients and doctors truly need, when. Joining us for the conversation are General Partner Julie Yoo, physician entrepreneur Ivor Horn, a primary care pediatrician for more than 20 years, and Jeff Kaditz, CEO and founder of Q.bio, a platform that identifies and monitors each individual’s biggest health risks.

The problem of “dark data” in healthcare isn’t just a feel-good empowerment thing, but a structural issue that leads to miscommunication and extra friction, different players in the entire healthcare sy...

Whether you’re an academic seeking to move out of research and into industry, or simply interested in working at a bio startup, this episode of the a16z Podcast is for you. It covers everything from how to build a bran...

Given concern around data breaches, the EU Parliament finally passed GDPR (General Data Protection Regulation) after four years of preparation and debate; it goes into enforcement on May 25, 2018. Though it originated in...

APIs (application programming interfaces), observe the guests in this episode of the a16z Podcast, can be described as everything from Lego building blocks to Tetris to front doors to even veins in the human body. Becau...

There are many reasons why we’re in an “A.I. spring” after multiple “A.I. winters” — but how then do we tease apart what’s real vs. what’s hype when it comes to the (legitimate!) e...

Drug design is fundamentally a data science problem. Naturally, data science starts with the data, with a key challenge being the creation of accurate and highly reproducible data at scale. But data on its own are useles...

“Hic sunt dracones” (Here Be Dragons)

watch time: 20 minutes

Editor’s Note: Vijay Pande (“pahn-day”) is Andreessen Horowitz’ newest General Partner, dedicated to our new bio fund.

In the expansive world of software, I have a particular fondness and passion for the arcane yet critically important area of system software. For my entire career, whether as a programmer, kernel hack, or CEO, I have bee...

Here at a16z, we treat “big data” and “machine learning” as connected activities. People have been talking about the need for more ‘analysis’ and insight in big data, which is obviously important, bec...

[vimeo 109851729 w=720 h=404]